{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:44:54Z","timestamp":1791582294244,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsmedizin Rostock"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Inflammatory demyelination, a hallmark of multiple sclerosis (MS) lesions, leads to functional impairments and progressive axonal loss over time. Although remyelination is thought to protect axons, endogenous regenerative processes are often incomplete or fail entirely in many MS patients. While the precise reasons for remyelination failure remain unclear, repeated demyelination in previously affected white matter regions is a recognized contributing factor. In a previous study, we demonstrated that the sphingosine-1-phosphate modulator Siponimod ameliorates metabolic oligodendrocyte injury in an MS animal model. In this study, we explored the potential of Siponimod to enhance remyelination in a non-supportive environment. To this end, male mice were subjected to Cuprizone intoxication for seven weeks. From the onset of the fifth week, when oligodendrocyte progenitor cells begin to differentiate, mice were administered either a vehicle or Siponimod solution. Post-treatment, brain specimens were processed for (immune-) histochemical analyses. After four weeks of Cuprizone intoxication, staining intensities for various myelination markers, were significantly reduced. At the end of week seven, loss of myelin staining intensities was still pronounced, but anti-myelin basic protein (MBP) and myelin-associated glycoprotein (MAG) expression was significantly higher in Siponimod- versus vehicle-treated mice. Consistent with this finding, densities of OLIG2\n                    <jats:sup>+<\/jats:sup>\n                    oligodendrocytes significantly recovered in Siponimod-treated but not in vehicle-treated mice. This enhanced recovery was paralleled by the trend of lower densities of Ki67\n                    <jats:sup>+<\/jats:sup>\n                    proliferating oligodendrocyte progenitor cells. Our findings suggest that Siponimod has modest pro-regenerative capacities, partly explaining the amelioration of disease progression in secondary progressive MS patients.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-87825-8","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T07:07:18Z","timestamp":1738652838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Siponimod supports remyelination in the non-supportive environment"],"prefix":"10.1038","volume":"15","author":[{"given":"Johann","family":"Kr\u00fcger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Newshan","family":"Behrangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schliep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Heinig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Vankriekelsvenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Wigger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"issue":"8","key":"87825_CR1","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1212\/WNL.0000000000012323","volume":"97","author":"BAC Cree","year":"2021","unstructured":"Cree, B. A. C. et al. Secondary progressive multiple sclerosis. Neurology 97(8), 378\u2013388 (2021).","journal-title":"Neurology"},{"issue":"2","key":"87825_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1365-2990.1993.tb00424.x","volume":"19","author":"J Gilson","year":"1993","unstructured":"Gilson, J. & Blakemore, W. F. Failure of remyelination in areas of demyelination produced in the spinal cord of old rats. Neuropathol. Appl. Neurobiol. 19(2), 173\u2013181 (1993).","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"87825_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/(SICI)1098-1136(20000101)29:1<102::AID-GLIA12>3.0.CO;2-1","volume":"29","author":"S Shields","year":"2000","unstructured":"Shields, S. et al. Remyelination occurs as extensively but more slowly in old rats compared to young rats following fliotoxin-induced CNS demyelination. Glia 29(1), 102 (2000).","journal-title":"Glia"},{"key":"87825_CR4","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.18246","author":"F Mei","year":"2016","unstructured":"Mei, F. et al. Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery. Elife https:\/\/doi.org\/10.7554\/eLife.18246 (2016).","journal-title":"Elife"},{"issue":"11","key":"87825_CR5","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrn2480","volume":"9","author":"RJ Franklin","year":"2008","unstructured":"Franklin, R. J. & Ffrench-Constant, C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 9(11), 839\u2013855 (2008).","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"87825_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ana.410050105","volume":"5","author":"JW Prineas","year":"1979","unstructured":"Prineas, J. W. & Connell, F. Remyelination in multiple sclerosis. Ann. Neurol. 5(1), 22\u201331 (1979).","journal-title":"Ann. Neurol."},{"issue":"2","key":"87825_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ana.410330203","volume":"33","author":"JW Prineas","year":"1993","unstructured":"Prineas, J. W. et al. Multiple sclerosis: remyelination of nascent lesions. Ann. Neurol. 33(2), 137\u2013151 (1993).","journal-title":"Ann. Neurol."},{"issue":"Pt 6","key":"87825_CR8","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1093\/brain\/awn080","volume":"131","author":"KA Irvine","year":"2008","unstructured":"Irvine, K. A. & Blakemore, W. F. Remyelination protects axons from demyelination-associated axon degeneration. Brain 131(Pt 6), 1464\u20131477 (2008).","journal-title":"Brain"},{"issue":"Pt 3","key":"87825_CR9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/brain\/116.3.681","volume":"116","author":"JW Prineas","year":"1993","unstructured":"Prineas, J. W. et al. Multiple sclerosis. Pathology of recurrent lesions. Brain 116(Pt 3), 681\u2013693 (1993).","journal-title":"Brain"},{"issue":"1","key":"87825_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ana.410250107","volume":"25","author":"EW Willoughby","year":"1989","unstructured":"Willoughby, E. W. et al. Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients. Ann. Neurol. 25(1), 43\u201349 (1989).","journal-title":"Ann. Neurol."},{"key":"87825_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.nicl.2014.06.009","volume":"6","author":"RA Brown","year":"2014","unstructured":"Brown, R. A., Narayanan, S. & Arnold, D. L. Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis. Neuroimage Clin. 6, 20\u201325 (2014).","journal-title":"Neuroimage Clin."},{"issue":"2","key":"87825_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/BF00689988","volume":"53","author":"ES Johnson","year":"1981","unstructured":"Johnson, E. S. & Ludwin, S. K. The demonstration of recurrent demyelination and remyelination of axons in the central nervous system. Acta Neuropathol. 53(2), 93\u201398 (1981).","journal-title":"Acta Neuropathol."},{"issue":"1","key":"87825_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1046\/j.0305-1846.2001.00301.x","volume":"27","author":"JL Mason","year":"2001","unstructured":"Mason, J. L. et al. Episodic demyelination and subsequent remyelination within the murine central nervous system: changes in axonal calibre. Neuropathol. Appl. Neurobiol. 27(1), 50\u201358 (2001).","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"Pt 6","key":"87825_CR14","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1093\/brain\/awg126","volume":"126","author":"J Penderis","year":"2003","unstructured":"Penderis, J., Shields, S. A. & Franklin, R. J. Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system. Brain 126(Pt 6), 1382\u20131391 (2003).","journal-title":"Brain"},{"issue":"6","key":"87825_CR15","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00401-009-0591-3","volume":"118","author":"M Kipp","year":"2009","unstructured":"Kipp, M. et al. The cuprizone animal model: new insights into an old story. Acta Neuropathol. 118(6), 723\u2013736 (2009).","journal-title":"Acta Neuropathol."},{"issue":"3","key":"87825_CR16","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3390\/ijms25031445","volume":"25","author":"M Kipp","year":"2024","unstructured":"Kipp, M. How to use the cuprizone model to study de- and remyelination. Int. J. Mol. Sci. 25(3), 1445 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"87825_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12031-012-9773-x","volume":"48","author":"JP Buschmann","year":"2012","unstructured":"Buschmann, J. P. et al. Inflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cuprizone-induced demyelination. J. Mol. Neurosci. 48(1), 66\u201376 (2012).","journal-title":"J. Mol. Neurosci."},{"issue":"1","key":"87825_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.nbd.2011.09.008","volume":"45","author":"EV Voss","year":"2012","unstructured":"Voss, E. V. et al. Characterisation of microglia during de- and remyelination: can they create a repair promoting environment?. Neurobiol. Dis. 45(1), 519\u2013528 (2012).","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"87825_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/BF01102943","volume":"1","author":"WF Blakemore","year":"1972","unstructured":"Blakemore, W. F. Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice. J. Neurocytol. 1(4), 413\u2013426 (1972).","journal-title":"J. Neurocytol."},{"issue":"3","key":"87825_CR20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s12640-021-00331-3","volume":"39","author":"D Buonvicino","year":"2021","unstructured":"Buonvicino, D., Ranieri, G. & Chiarugi, A. Cuprizone-dependent de\/remyelination responses and functional correlates in mouse strains adopted to model relapsing, chronic and progressive experimental autoimmune encephalomyelitis. Neurotox. Res. 39(3), 658\u2013666 (2021).","journal-title":"Neurotox. Res."},{"issue":"40","key":"87825_CR21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2204509119","volume":"119","author":"N Behrangi","year":"2022","unstructured":"Behrangi, N. et al. Siponimod ameliorates metabolic oligodendrocyte injury via the sphingosine-1 phosphate receptor 5. Proc. Natl. Acad. Sci. U. S. A. 119(40), e2204509119 (2022).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"87825_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/cells8010024","volume":"8","author":"N Behrangi","year":"2019","unstructured":"Behrangi, N., Fischbach, F. & Kipp, M. Mechanism of siponimod: Anti-inflammatory and neuroprotective mode of action. Cells 8(1), 24 (2019).","journal-title":"Cells"},{"issue":"7","key":"87825_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol. 18(7), e3000411 (2020).","journal-title":"PLoS Biol."},{"key":"87825_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.brainres.2009.06.005","volume":"1283","author":"V Gudi","year":"2009","unstructured":"Gudi, V. et al. Regional differences between grey and white matter in cuprizone induced demyelination. Brain Res. 1283, 127\u2013138 (2009).","journal-title":"Brain Res."},{"issue":"12","key":"87825_CR25","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/glia.23229","volume":"65","author":"EG Baxi","year":"2017","unstructured":"Baxi, E. G. et al. Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced demyelination. Glia 65(12), 2087\u20132098 (2017).","journal-title":"Glia"},{"issue":"3","key":"87825_CR26","first-page":"683","volume":"95","author":"SK Ludwin","year":"1979","unstructured":"Ludwin, S. K. An autoradiographic study of cellular proliferation in remyelination of the central nervous system. Am. J. Pathol. 95(3), 683\u2013696 (1979).","journal-title":"Am. J. Pathol."},{"issue":"3","key":"87825_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/1097-4547(20000801)61:3<251::AID-JNR3>3.0.CO;2-W","volume":"61","author":"JL Mason","year":"2000","unstructured":"Mason, J. L. et al. Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination\/remyelination. J. Neurosci. Res. 61(3), 251\u2013262 (2000).","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"87825_CR28","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s12031-017-0903-3","volume":"61","author":"T Hochstrasser","year":"2017","unstructured":"Hochstrasser, T. et al. Cuprizone-containing pellets are less potent to induce consistent demyelination in the corpus callosum of C57BL\/6 mice. J. Mol. Neurosci. 61(4), 617\u2013624 (2017).","journal-title":"J. Mol. Neurosci."},{"key":"87825_CR29","volume-title":"The Mouse Brain in Stereotaxic Coordinates","author":"G Paxinos","year":"2007","unstructured":"Paxinos, G. et al. The Mouse Brain in Stereotaxic Coordinates (Elsevier Science, 2007)."},{"issue":"11","key":"87825_CR30","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.3390\/cells8111363","volume":"8","author":"S Nyamoya","year":"2019","unstructured":"Nyamoya, S. et al. Laquinimod supports remyelination in non-supportive environments. Cells 8(11), 1363 (2019).","journal-title":"Cells"},{"issue":"4","key":"87825_CR31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/00005072-196710000-00012","volume":"26","author":"J Naoumenko","year":"1967","unstructured":"Naoumenko, J. & Feigin, I. A stable silver solution for axon staining in paraffin sections. J. Neuropathol. Exp. Neurol. 26(4), 669\u2013673 (1967).","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"87825_CR32","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7(1), 16878 (2017).","journal-title":"Sci. Rep."},{"key":"87825_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.brainres.2016.08.048","volume":"1650","author":"KM H\u00f6flich","year":"2016","unstructured":"H\u00f6flich, K. M. et al. Acute axonal damage in three different murine models of multiple sclerosis: A comparative approach. Brain Res. 1650, 125\u2013133 (2016).","journal-title":"Brain Res."},{"key":"87825_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.709596","volume":"16","author":"S Joost","year":"2022","unstructured":"Joost, S. et al. Cuprizone intoxication results in myelin vacuole formation. Front. Cell. Neurosci. 16, 709596 (2022).","journal-title":"Front. Cell. Neurosci."},{"issue":"5","key":"87825_CR35","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/S0002-9440(10)63726-1","volume":"164","author":"JL Mason","year":"2004","unstructured":"Mason, J. L. et al. Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am. J. Pathol. 164(5), 1673\u20131682 (2004).","journal-title":"Am. J. Pathol."},{"issue":"3","key":"87825_CR36","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1177\/1352458512438723","volume":"18","author":"M Kipp","year":"2012","unstructured":"Kipp, M. & Amor, S. FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination. Mult. Scler. J. 18(3), 258\u2013263 (2012).","journal-title":"Mult. Scler. J."},{"issue":"6","key":"87825_CR37","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.2353\/ajpath.2010.091234","volume":"176","author":"VE Miron","year":"2010","unstructured":"Miron, V. E. et al. Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices. Am. J. Pathol. 176(6), 2682\u20132694 (2010).","journal-title":"Am. J. Pathol."},{"issue":"3","key":"87825_CR38","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/glia.22272","volume":"60","author":"GK Sheridan","year":"2011","unstructured":"Sheridan, G. K. & Dev, K. K. S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures. Glia 60(3), 382\u2013392 (2011).","journal-title":"Glia"},{"issue":"4","key":"87825_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00401-020-02193-z","volume":"140","author":"F Cignarella","year":"2020","unstructured":"Cignarella, F. et al. TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis. Acta Neuropathol. 140(4), 513\u2013534 (2020).","journal-title":"Acta Neuropathol."},{"issue":"5","key":"87825_CR40","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1172\/JCI77983","volume":"125","author":"PL Poliani","year":"2015","unstructured":"Poliani, P. L. et al. TREM2 sustains microglial expansion during aging and response to demyelination. J. Clin. Investig. 125(5), 2161\u20132170 (2015).","journal-title":"J. Clin. Investig."},{"issue":"7","key":"87825_CR41","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/glia.24148","volume":"70","author":"MK Sen","year":"2022","unstructured":"Sen, M. K. et al. The roles of microglia and astrocytes in phagocytosis and myelination: Insights from the cuprizone model of multiple sclerosis. Glia 70(7), 1215\u20131250 (2022).","journal-title":"Glia"},{"issue":"10","key":"87825_CR42","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/glia.22367","volume":"60","author":"T Clarner","year":"2012","unstructured":"Clarner, T. et al. Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions. Glia 60(10), 1468\u20131480 (2012).","journal-title":"Glia"},{"issue":"21","key":"87825_CR43","doi-asserted-by":"publisher","first-page":"13278","DOI":"10.3390\/ijms232113278","volume":"23","author":"J Gruchot","year":"2022","unstructured":"Gruchot, J. et al. Siponimod Modulates the Reaction of Microglial Cells to Pro-Inflammatory Stimulation. Int. J. Mol. Sci. 23(21), 13278 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"87825_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099444","volume":"9","author":"AJ Pritchard","year":"2014","unstructured":"Pritchard, A. J., Mir, A. K. & Dev, K. K. Fingolimod attenuates splenocyte-induced demyelination in cerebellar slice cultures. PLoS One 9(6), e99444 (2014).","journal-title":"PLoS One"},{"issue":"15","key":"87825_CR45","doi-asserted-by":"publisher","first-page":"15396","DOI":"10.1074\/jbc.M314291200","volume":"279","author":"ML Allende","year":"2004","unstructured":"Allende, M. L. et al. Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J. Biol. Chem. 279(15), 15396\u201315401 (2004).","journal-title":"J. Biol. Chem."},{"issue":"3","key":"87825_CR46","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1096\/fj.03-0910fje","volume":"18","author":"MH Gr\u00e4ler","year":"2004","unstructured":"Gr\u00e4ler, M. H. & Goetzl, E. J. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J. 18(3), 551\u2013553 (2004).","journal-title":"FASEB J."},{"issue":"6972","key":"87825_CR47","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature02284","volume":"427","author":"M Matloubian","year":"2004","unstructured":"Matloubian, M. et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427(6972), 355\u2013360 (2004).","journal-title":"Nature"},{"key":"87825_CR48","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001161","author":"M Dietrich","year":"2022","unstructured":"Dietrich, M. et al. Increased remyelination and proregenerative microglia under siponimod therapy in mechanistic models. Neurol. Neuroimmunol. Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000001161 (2022).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"11","key":"87825_CR49","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1177\/1352458517721355","volume":"24","author":"A Mannioui","year":"2018","unstructured":"Mannioui, A. et al. The Xenopus tadpole: An in vivo model to screen drugs favoring remyelination. Mult. Scler. 24(11), 1421\u20131432 (2018).","journal-title":"Mult. Scler."},{"key":"87825_CR50","doi-asserted-by":"publisher","first-page":"1068736","DOI":"10.3389\/fnbeh.2022.1068736","volume":"16","author":"KM Al-Otaibi","year":"2022","unstructured":"Al-Otaibi, K. M. et al. Therapeutic effect of combination vitamin D3 and siponimod on remyelination and modulate microglia activation in cuprizone mouse model of multiple sclerosis. Front. Behav. Neurosci. 16, 1068736 (2022).","journal-title":"Front. Behav. Neurosci."},{"issue":"2","key":"87825_CR51","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12640-013-9380-9","volume":"24","author":"K B\u00e9nardais","year":"2013","unstructured":"B\u00e9nardais, K. et al. Cuprizone [bis(cyclohexylidenehydrazide)] is selectively toxic for mature oligodendrocytes. Neurotox. Res. 24(2), 244\u2013250 (2013).","journal-title":"Neurotox. Res."},{"issue":"5","key":"87825_CR52","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.neuro.2010.05.008","volume":"31","author":"F Benetti","year":"2010","unstructured":"Benetti, F. et al. Cuprizone neurotoxicity, copper deficiency and neurodegeneration. Neurotoxicology 31(5), 509\u2013517 (2010).","journal-title":"Neurotoxicology"},{"issue":"2","key":"87825_CR53","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0022-510X(99)00181-1","volume":"168","author":"W Cammer","year":"1999","unstructured":"Cammer, W. The neurotoxicant, cuprizone, retards the differentiation of oligodendrocytes in vitro. J. Neurol. Sci. 168(2), 116\u2013120 (1999).","journal-title":"J. Neurol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87825-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87825-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87825-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T07:07:27Z","timestamp":1738652847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87825-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["87825"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-87825-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"29 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4216"}}